The Intracept Procedure by Relievant
  • Intracept
    • Intracept Overview
    • Basics
    • Vertebrogenic Pain
    • Procedure
    • System
  • Living Proof
    • Living Proof Overview
    • From Patients
    • From Physicians
    • Clinical Evidence
  • Resources
    • Resources Overview
    • Insurance Coverage
    • Physician Reimbursement
    • Modic Changes
  • Company
    • Company Overview
    • History
    • Leadership & Board
    • Investors
    • Careers
  • Find a Doctor
  • News & Events
Select Page

Relievant Medsystems Announces Publication of ASPN Guidelines on the Diagnosis and Treatment of Vertebrogenic Low Back Pain with Basivertebral Nerve Ablation

by Ben Anderson | Sep 20, 2022 | news

Published guidelines with highest evidence rating provide physicians confidence to adopt basivertebral nerve ablation as first-line treatment MINNEAPOLIS – September 20, 2022 – Relievant Medsystems, a company focused on transforming the diagnosis and treatment of...

NBC News’ TODAY Features the Minimally Invasive Intracept® Procedure for Chronic Vertebrogenic Low Back Pain

by wpengine | Jun 13, 2022 | news

Relievant Medsystems shared today that the company’s breakthrough chronic low back pain treatment, the Intracept Procedure, was featured on NBC’s TODAY this morning. The full segment can be viewed here. “This is an exciting story, not only for the patients I’ve...

Relievant Medsystems Announces New Category I CPT Codes for Intracept® Procedure

by Jason Rutten | Dec 30, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today that new Category I Current Procedural Terminology (CPT) codes for the Intracept Procedure are in effect as of January 1, 2022....

Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Demonstrating Long-Term Relief for Chronic Low Back Pain 24 Months Post-Procedure

by Jason Rutten | Nov 29, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month results from a Level 1, prospective, randomized, multi-center trial (INTRACEPT) that further validate the safety,...

Relievant Medsystems Announces New Vertebrogenic Low Back Pain ICD-10 Diagnosis Code

by Jason Rutten | Sep 29, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth Revision,...

Relievant Medsystems Announces Appointment of Dave Amerson to Board of Directors

by Jason Rutten | Jul 1, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the appointment of Dave Amerson to the Company’s Board of Directors. “It is with great pleasure that I welcome Dave to our Board...
« Older Entries
Next Entries »

Recent Posts

  • Principal Quality Engineer
  • Finance Manager
  • Senior Manager, Supply Chain
  • Relievant Medsystems Announces Positive Local Coverage Determination by Palmetto GBA for Basivertebral Nerve Ablation in Treating Chronic Vertebrogenic Low Back Pain
  • Clinical Specialist – Oklahoma

Recent Comments

No comments to show.
Relievant logo
  • Intracept
    • Intracept Overview
    • Basics
    • Vertebrogenic Pain
    • Procedure
    • System
  • Living Proof
    • Living Proof Overview
    • From Patients
    • From Physicians
    • From Clinical Trials
  • Resources
    • Resources Overview
    • Insurance Coverage
    • Physician Reimbursement
    • Modic Changes
  • Company
    • Company Overview
    • History
    • Leadership & Board
    • Investors
    • Careers

Contact:

Relievant Medsystems, Inc.
Corporate Headquarters
7201 Metro Blvd #300
Edina, MN 55439
650-368-1000

 

Development and Operations
1230 Midas Way, Suite 200
Sunnyvale, CA 94085

Contact Us
Follow Us:
  • Follow
  • Follow
  • Follow
  • Follow
MKT 0327 Rev. B © 2023 Relievant Medsystems, Inc. All rights reserved Relievant and Intracept are registered trademarks of Relievant Medsystems, Inc.
Terms of Use Privacy Policy